NYSE:AB
AllianceBernstein Holding LP Stock News
$33.85
-0.110 (-0.324%)
At Close: May 17, 2024
AB Science announces that Health Canada has started the review of New Drug Submission for masitinib in the treatment of ALS
08:46pm, Thursday, 26'th May 2022 GlobeNewswire Inc.
PRESS RELEASE
AB Science annonce que Health Canada a démarré la revue du dossier d’enregistrement du masitinib dans le traitement de la SLA
08:46pm, Thursday, 26'th May 2022 GlobeNewswire Inc.
COMMUNIQUE DE PRESSE
Equitable Holdings (EQH) Cheers Investors With 11% Dividend Hike
05:25pm, Friday, 20'th May 2022 Zacks Investment Research
Based on the increased rate, Equitable Holdings' (EQH) annual dividend comes to 80 cents per share.
AllianceBernstein (AB) Stock Down as April AUM Declines 6.8%
12:57pm, Thursday, 12'th May 2022 Zacks Investment Research
Dismal market performance and outflows lead to a decline in AllianceBernstein's (AB) April AUM balance.
Wall Street giant's move to Nashville saves $80M a year — but some workers feel lost
12:49pm, Thursday, 12'th May 2022
Wall Street giant AllianceBernstein, which moved its headquarters from New York City to Nashville four years ago, is reaping massive savings from the relocation -- but some employees aren't thrilled,
AllianceBernstein (AB) Stock Down as April AUM Declines 6.8%
10:32am, Thursday, 12'th May 2022
Dismal market performance and outflows lead to a decline in AllianceBernstein's (AB) April AUM balance.
AB Science reports its revenues for the year 2021 and provides an update on its activities
04:33pm, Friday, 29'th Apr 2022 GlobeNewswire Inc.
PRESS RELEASE
AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2021 et présente un point sur ses activités
04:33pm, Friday, 29'th Apr 2022 GlobeNewswire Inc.
COMMUNIQUE DE PRESSE
AllianceBernstein Holding L.P.'s (AB) CEO Seth Bernstein on Q1 2022 Results - Earnings Call Transcript
02:07pm, Friday, 29'th Apr 2022
AllianceBernstein Holding L.P. (NYSE:AB ) Q1 2022 Earnings Conference Call April 29, 2022 9:00 AM ET Company Participants Mark Griffin - Head, Investor Relations Seth Bernstein - President and CEO Bil
COMMUNIQUE DE PRESSE
AB Science announced the continuation of the Phase 2 study evaluating masitinib in combination with isoquercetin in COVID-19, following the recommendation of the Data and Safety Monitoring Board (DSMB)
06:01am, Thursday, 28'th Apr 2022 GlobeNewswire Inc.
PRESS RELEASE
48 Inflation Busters Feature 8 Ideal Dividend Dogs
05:16am, Thursday, 28'th Apr 2022 Seeking Alpha
March-April 2022, UBS, Kiplinger, and Barron's analysts/reporters combined to list 5 sets of stocks sorted as inflation busters for 2022, featuring 8 dividend dogs.
AB to Report First Quarter 2022 Results on April 29, 2022
01:21pm, Thursday, 14'th Apr 2022
NASHVILLE, Tenn., April 14, 2022 /PRNewswire/ -- AllianceBernstein L.P.
3 Stocks to Buy to Battle Rapidly Rising Interest Rates
07:59pm, Wednesday, 13'th Apr 2022
Here are three top stocks to buy for investors concerned about what this rising interest rate environment could mean for their portfolio. The post 3 Stocks to Buy to Battle Rapidly Rising Interest Rat
Franklin Resources (BEN) Completes Lexington Partners Buyout
02:50pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
Franklin (BEN) completes the acquisition of Lexington Partners L.P. in a cash deal of $1.75 billion to boost its alternative asset business.
